人工智能用于预防痴呆症
Danielle Newby1, Vasiliki Orgeta2, Charles R Marshall3,4
1Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|October 14, 2023
概括
人工智能和机器学习通过改进风险分析和临床试验招聘来提高痴呆症预防的前景. 这些技术可以个性化预防策略,加速治疗痴呆症的药物开发.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 公共卫生 公共卫生
背景情况:
- 痴呆症预防研究已经确定了许多可修改的风险因素,但它们的相互作用和因果作用需要进一步调查.
- 目前用于识别临床试验和药物开发的高风险个体的方法是不理想的.
- 人工智能 (AI) 和机器学习 (ML) 提供了潜在的解决方案,以改进对痴呆风险因素的理解和应用.
研究的目的:
- 探索机器学习 (ML) 方法在痴呆症预防中的应用.
- 评估ML在痴呆症预防策略中的当前用途,局限性和未来潜力.
- 突出人工智能如何提高痴呆风险管理和临床试验设计的精度.
主要方法:
- 审查和讨论在痴呆症预防研究中示例机器学习 (ML) 应用.
- 评估当前基于ML的风险分析和试验招聘工具的性能和局限性.
- 分析AI和ML在药物重用和优先治疗方面的潜力.
主要成果:
- 机器学习模型显示了开发改进的风险分析和临床试验招聘工具的潜力,可能降低成本并提高试验效率.
- ML可以为药物重新定位提供信息,并有助于优先考虑痴呆症疾病修饰疗法.
- 目前在痴呆症预防方面的ML应用有限,但该技术对未来的进步具有重大前景.
结论:
- 机器学习 (ML) 准备在痴呆症预防中显著提高精度,尽管它尚未被广泛采用.
- 人工智能可以个性化风险管理工具,并针对特定的患者群体进行临床试验,改善痴呆症预防结果.
- 需要进一步的研究,以获得对终身痴呆症风险因素的因果洞察力,以便在预防工作中充分利用人工智能.
相关概念视频
Alzheimer's Disease: Treatment
211
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
211
Alzheimer's Disease: Overview
503
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
503
Dementia
121
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
121
Non-equilibrium in the Cell
4.5K
An important concept in studying metabolism and energy is that of chemical equilibrium. Most chemical reactions are reversible. They can proceed in both directions, releasing energy into their environment in one direction, and absorbing it from the environment in the other direction. The same is true for the chemical reactions involved in cell metabolism, such as the breaking down and building up of proteins into and from individual amino acids, respectively. Reactants within a closed system...
4.5K
Cognitive Development During Adulthood
126
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
126
Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283


